Dose Escalation of Hypofractionated Radiation Therapy in Patients With Metastatic Cancer
Phase 1
Completed
- Conditions
- MelanomaTumorCarcinomaCancerSarcoma
- Interventions
- Radiation: Hypofractionated RT
- First Posted Date
- 2010-10-06
- Last Posted Date
- 2018-09-12
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 63
- Registration Number
- NCT01215500
- Locations
- 🇺🇸
University of Chicago, Chicago, Illinois, United States
Genetic Determinants of Response to Neoadjuvant Cisplatin-based Chemotherapy in Urothelial Cancer
Completed
- Conditions
- Urothelial Cancer
- First Posted Date
- 2010-09-21
- Last Posted Date
- 2018-05-04
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 79
- Registration Number
- NCT01206426
- Locations
- 🇺🇸
University of Chicago, Chicago, Illinois, United States
Laser Based Focal Ablation of Low Grade Prostate Cancer
Not Applicable
Completed
- Conditions
- Low Grade Prostate Cancer
- Interventions
- Procedure: Laser-based thermotherapy
- First Posted Date
- 2010-09-01
- Last Posted Date
- 2014-03-27
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 9
- Registration Number
- NCT01192438
- Locations
- 🇺🇸
University of Chicago, Chicago, Illinois, United States
A Randomized Study of Testosterone Replacement in Patients With Low Risk Hormone Refractory Prostate Cancer
Phase 1
Completed
- Conditions
- Prostate Cancer
- Interventions
- First Posted Date
- 2010-08-24
- Last Posted Date
- 2023-11-29
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 15
- Registration Number
- NCT01187485
- Locations
- 🇺🇸
University of Chicago, Chicago, Illinois, United States
Organ Preservation in the Multispeciality Therapy of Stage II-IV Locally Advanced Head and Neck Cancer
Completed
- Conditions
- Head and Neck Cancer
- First Posted Date
- 2010-08-24
- Last Posted Date
- 2023-11-29
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 35
- Registration Number
- NCT01187472
- Locations
- 🇺🇸
The University of Chicago, Chicago, Illinois, United States
A Phase II Study of 250-mg ZD1839 Monotherapy in Recurrent or Metastatic or Both Recurrent and Metastatic Squamous Cell Carcinoma
Phase 2
Completed
- Conditions
- Head and Neck Cancer
- Interventions
- Drug: ZD1839 (IRESSA)
- First Posted Date
- 2010-08-19
- Last Posted Date
- 2023-11-29
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 46
- Registration Number
- NCT01185158
- Locations
- 🇺🇸
The University of Chicago Medical Center, Chicago, Illinois, United States
Trial of Induction Chemotherapy With Carboplatin and Paclitaxel, Followed by Concurrent Chemotherapy/Radiation Therapy With ZD1839 (IRESSA), 5-FU, Hydroxyurea, and Twice-Daily Radiation, Followed by Adjuvant ZD1839 Monotherapy in Patients With Locally Advanced Head & Neck Cancer
Phase 2
Completed
- Conditions
- Head and Neck Cancer
- Interventions
- Drug: ZD 1839 500mg
- First Posted Date
- 2010-08-19
- Last Posted Date
- 2023-05-11
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 70
- Registration Number
- NCT01185171
- Locations
- 🇺🇸
The University of Chicago Medical Center, Chicago, Illinois, United States
A Genotype-guided Study of Irinotecan Administered in Combination With 5-fluorouracil/Leucovorin (FOLFIRI) and Bevacizumab in Advanced Colorectal Cancer Patients
Phase 1
Completed
- Conditions
- Metastatic Colorectal Cancer
- Interventions
- Drug: FOLFIRI, Avastin, Irinotecan
- First Posted Date
- 2010-08-17
- Last Posted Date
- 2019-04-22
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 17
- Registration Number
- NCT01183494
- Locations
- 🇮🇹
CRO-National Cancer Institute, Aviano, Italy
🇺🇸The University of Chicago, Chicago, Illinois, United States
Comparison of Ultrasound Guided Low Epidural Catheter Placement With Standard Epidural Catheter Placement
Completed
- Conditions
- Labor Pain
- First Posted Date
- 2010-08-16
- Last Posted Date
- 2016-11-01
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 90
- Registration Number
- NCT01182220
- Locations
- 🇺🇸
University of Chicago Hospitals, Chicago, Illinois, United States
Celiac Disease Database
Completed
- Conditions
- Celiac Disease
- First Posted Date
- 2010-07-30
- Last Posted Date
- 2024-05-16
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 1090
- Registration Number
- NCT01172665
- Locations
- 🇺🇸
The University of Chicago Medical Center, Chicago, Illinois, United States
© Copyright 2025. All Rights Reserved by MedPath